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Abstract  
Objectives: To determine the extent of pharmacists' participation in methadone 
services, type of services provided, views on current service provision and 
suggestions for future service developments.  
 
Methods and setting: An anonymous postal questionnaire was distributed to all 
community pharmacies in the greater Dublin area (n=291) and in Glasgow (n=200), 
excluding 12 pharmacies in each city that had participated in the pilot study.  
 
Key findings: The response rates were 50% (146/291) and 56% (112/200) for Dublin 
and Glasgow respectively. Participation in methadone services was considerably 
higher in Glasgow (80%, 90/112, of respondents) than in Dublin (38%, 55/146) and 
the number of patients per pharmacy was higher. A majority of pharmacists 
participating in methadone services (76% in Dublin, 92% in Glasgow) felt they had a 
professional responsibility to provide such services. In both cities the most common 
grounds for lack of service provision were business reasons, including risk to staff or 
property and theft. Current non-participants identified increased demand for the 
service and improved security measures as two factors that may encourage their 
participation in the future.  
 
Conclusion: Pharmacists in Dublin and Glasgow differed significantly in the extent 
and types of services provided. This may be because a structured scheme was in 
place in Glasgow but not in Dublin at the time of the study. Despite these differences 
in service provision, views were very similar in both cities.  
INTRODUCTION  
The misuse of drugs is a major health concern for many European cities, not least 
Dublin and Glasgow, which have the highest rates of injected heroin use in Europe. 
The number of heroin users has been estimated at 8,000-10,000 (0.8-1%) and 8,500 
(0.9%) for Dublin and Glasgow respectively (Irish Ministerial Task Force, 1996; 
Frischer, Goldberg, Taylor, & Bloor, 1997). The use of methadone as a maintenance 
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treatment is supported by an extensive evidence base (Dole and Nyswander, 1965; 
Farrell et al., 1994; Ward, Hall, & Mattick, 1999). The supervised consumption of 
methadone within a community pharmacy under the direct supervision of a 
pharmacist is recognized as an effective means of avoiding overdose or illicit 
diversion of methadone and has demonstrated substantial benefits for patients 
(McBride, Ali, & Atkinson, 1994; Scott, Jay, Keith, Oliver, & Cassidy, 1998). However, 
despite this research, there exists a wide variation in the nature and extent of 
community pharmacy involvement in service provision between Dublin and Glasgow 
(Pharmaceutical Society of Ireland, 1996; Roberts, McNulty, Gruer, Scott, & Bryson, 
1998). 
An established and well-run scheme with tight controls had been in operation in 
Glasgow since May 1994 (Gruer et al., 1997; Roberts et al., 1998; Scott, Burnett, & 
McNulty, 1994; Scott et al., 1998). In 1994, 45% of all community pharmacists in 
Glasgow were either already supervising the consumption of methadone or were 
prepared to do so (Scott et al., 1994). In April 1995, the Glasgow Health Board began 
paying a small quarterly fee to community pharmacists who agreed to provide 
supervision, report every month on all methadone dispensing, undertake training 
(Mackie, 1996) and participate in audit. By April 1996, 59% of all the community 
pharmacies in Glasgow had agreed to supervise consumption of methadone on their 
premises (Gruer et al., 1997). This scheme included formal notification by the GP, 
pharmacists having the freedom to accept or reject new patients, prescriptions limited 
to 14 days supply and a central drug programme service to support and stabilize 
chaotic users, including shared-care protocols. 
No equivalent scheme was in place in Dublin at the time of this study. Prescribing 
and dispensing of methadone in Dublin was primarily to drug users enrolled in 
specialized clinics. In limited cases, where it was judged appropriate, arrangements 
were made for patients stabilized on methadone to be transferred to the care of GPs 
and community pharmacists. In such cases, the prescribing clinic doctor or GP would 
normally contact pharmacies nominated by the patients to seek the pharmacists' 
participation and discuss the programme of treatment. A central record of such 
arrangements was maintained by the clinics. However, a GP could independently 
prescribe methadone to any patient, and this prescription could be dispensed in any 
pharmacy without notification of a central authority (Irish Misuse of Drugs 
Regulations, 1988). Inevitably, these arrangements led to some patients obtaining 
methadone from more than one source. 
In 1996, the Pharmaceutical Society of Ireland published a policy document on drug 
abuse (Pharmaceutical Society of Ireland, 1996) to guide pharmacists involved in 
community-based methadone substitution. Following this publication it was decided 
to conduct a study in Ireland to determine the extent of pharmacy service provision 
and to obtain the views of community pharmacists to inform future service 
developments. The Glasgow scheme continued to develop; therefore, it was decided 
to compare Dublin and Glasgow owing to the similarly high rate of heroin use 
(Frischer et al., 1997; Irish Ministerial Task Force, 1996). This paper reports baseline 
methadone service provision together with the views of community pharmacists on 
their current and future involvement in such services in the two cities in 1997/1998. 
The findings of this study were used to inform future service provision in both cities. 
The methodology was repeated in 2002, and the second paper reports on the 
development of such services in both cities from baseline to 2002. 
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AIMS AND OBJECTIVES  
The aims of this study were to determine the extent and nature of the provision of 
community pharmacy methadone services in Dublin and Glasgow and to obtain 
pharmacists' views to inform decisions on future service provision. Objectives 
included comparing the extent of participation by pharmacies in methadone-
dispensing services, operational procedures, number of patients supported and types 
of services provided. In addition, pharmacists' views on current and future service 
developments were obtained. In particular, the study attempted to ascertain why 
pharmacists did or did not provide methadone services and, in cases where they did 
not provide a service, to determine what circumstances might lead them to do so in 
the future. 
METHODS  
In 1997, a postal questionnaire was developed subsequent to a review of the 
literature and discussions with pharmacists and researchers active in the area of 
drug misuse. The questionnaire was piloted in 12 community pharmacies in Dublin 
and 12 community pharmacies in Glasgow. Those pharmacies that participated in the 
pilot were randomly selected (using random number tables) from a list of pharmacies 
from both cities and therefore excluded from the main study. Following the pilot, the 
questionnaire was modified to distinguish between provision of methadone 
dispensing services for organic disease and opiate dependence, and participants 
were invited to restrict their responses to the latter. 
The final questionnaire contained 45 questions arranged in four sections, namely 
demographics, provision of methadone services, practical aspects of methadone 
supply and future developments. Following support from the local pharmaceutical 
committees and the Health Authority, the questionnaire was sent by post (November 
1997) to all pharmacies (excluding 12 pilot) in the greater Dublin area, identified from 
the telephone book (n=291) and all pharmacies (excluding 12 pilot) in Glasgow 
included in the National Health Service (NHS) Pharmaceutical List (n=200). The 
questionnaire was sent with a letter explaining the objectives of the study together 
with a postage paid envelope (with a local university address in each city) for the 
return of the questionnaire. The questionnaire was anonymous and no reminder was 
sent. 
If the pharmacist indicated that they did not provide methadone services to drug 
users, they were asked to indicate which, if any, of 10 given reasons were their 
reason(s) for not providing such a service. These were: opposition to provision of 
services to drug users; methadone programmes are considered to be ineffective; 
concern that other customers would object; business reasons—risk to staff, property, 
theft; pharmacy would be isolated as the only one in the area providing such a 
service; pharmacy is too busy to provide an efficient service; premises are not 
suitable for supervision of consumption; no request for such a service; there is no 
perceived need for such a service in the area; it is company policy/owner's decision. 
An open-text area requesting “other” responses followed these 10 possible reasons. 
These pharmacists were also asked what, if anything, would lead them to provide 
such a service in the future, and an open-text area was provided for the response. 
If the pharmacist indicated that they did provide methadone services to drug users, 
they were asked to indicate their reason(s) for providing such a service. Eight 
possible reasons were suggested: support of the provision of services to drug users; 
methadone programmes considered to be clinically effective; perceived professional 
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responsibility; business reasons—increases prescription volume; pharmacy is one of 
only a small number in the area providing such a service; requested by patients to 
provide a service; requested by GPs/clinics to provide a service; it is company 
policy/owner's decision. An open-text area for “other” responses followed these. 
Data processing and analysis  
A coding frame was devised and survey data were coded. The coded data were then 
entered into the computer package Microsoft AccessTM for analysis. Chi-squared 
analysis of categorical variables was performed using Microsoft ExcelTM. Statistical 
significance was tested for at a 5% level. 
 
RESULTS  
The response rates for the questionnaires were 50% (146/291) and 56% (112/200) 
for Dublin and Glasgow respectively. 
Demographics and extent of participation by pharmacies in methadone-
dispensing services  
The percentages of pharmacies in Dublin and Glasgow that provided methadone 
services for drug users were 38% (55/146) and 80% (90/112) respectively. Gender 
and employment status (pharmacy owner or employee) of all respondents are given 
in Table I. There was no statistically significant difference in gender or employment 
status between those respondents who did or did not provide methadone-dispensing 
services. 
Table I. Category of pharmacist who completed the questionnaire vs. numbers 
who dispense methadone for drug users 
 Dublin Glasgow 
Pharmacist 
category 
Total no. 
respondents 
No. who dispense 
methadone for drug 
users 
Total number of 
respondents 
Number who dispense 
methadone for drug 
users 
Male pharmacy 
owner 59 (40%) 25 (45%) 22 (20%) 19 (21%) 
Female pharmacy 
owner 33 (23%) 8 (15%) 16 (14%) 10 (11%) 
Male employee 25 (17%) 10 (18%) 24 (21%) 22 (24%) 
Female employee 29 (20%) 12 (22%) 50 (45%) 39 (43%) 
All pharmacists 146 (100%) 55 (100%) 112 (100%) 90 (100%) 
Year of registration and participation of respondents in methadone service provision 
are provided in Table II. Generally, the spread of year of registration was similar for 
both groups. Dublin pharmacists who were registered for 20 years or longer were 
less likely to provide methadone services than Glasgow pharmacists in the same 
category (χ2=21.3, df=1, p<0.005). 
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Table II. Year of registration of pharmacist who completed the questionnaire 
vs. numbers who dispense methadone for drug users. 
 Dublin Glasgow 
Year of 
registration 
Total no. 
respondents 
No. who dispense 
methadone for drug 
users 
Total no. 
respondents 
No. who dispense 
methadone for drug 
users 
1978 or before 40 (27%) 8 (15%)a 34 (30%) 25 (28%)a 
1979-1988 43 (29%) 20 (36%) 34 (30%) 27 (30%) 
1989-1998 52 (36%) 22 (40%) 39 (35%) 34 (38%) 
Not declared 11 (8%) 5 (9%) 5 (5%) 4 (4%) 
All pharmacists 146 (100%) 55 (100%) 112 (100%) 90 (100%) 
aχ2=21.3, df=1, p<0.005 
Pharmacy type was defined as single, small multiple (2-10), multiple (11-20) or large 
multiple (≥21). The numbers of pharmacies in each category for the two cities are 
shown in Table III. With the exception of single pharmacies in Glasgow (p<0.001), 
there was no significant difference between categories in terms of percentages 
providing methadone services to drug users compared with those who did not 
provide such services. 
Table III. Type of pharmacy and status with regard to provision of methadone 
services for drug users. 
 Dublin Glasgow 
Type of 
pharmacy 
No. who dispense 
methadone for 
drug users 
No. who don't 
dispense methadone 
for drug users 
No. who dispense 
methadone for 
drug users 
No. who don't 
dispense methadone 
for drug users 
Single 32 (58%)a 63 (69%) 27 (30%)a 10 (45%) 
Small multiple 20 (36%) 27 (30%) 34 (38%) 5 (23%) 
Multiple 3 (6%) 0 (0%) 8 (9%) 1 (4.5%) 
Large multiple 0 (0%) 1 (1%) 21 (23%) 5 (23%) 
Not declared 0 (0%) 0 (0%) 0 (0%) 1 (4.5%) 
Total 55 (100%) 91 (100%) 90 (100%) 22 (100%)  
asignificant difference, p<0.001 
Pharmacy prescription volume related to extent (of methadone services) provision is 
shown in Figures 1 and 2 for Dublin and Glasgow respectively. The most common 
volume of prescriptions was 2,001-4,000 items per month, with this category 
representing 46% of respondents for both Dublin and Glasgow. A significant 
difference was noted for all three categories of prescription volume between Dublin 
and Glasgow in terms of provision of methadone services (p=0.03). 
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Figure 1. Pharmacy prescription volume and methadone service provision in Dublin 
.  
   
Figure 2. Pharmacy prescription volume and methadone service provision in 
Glasgow.  
Views of non-providers on why they do not provide a methadone service  
The top five reasons for not providing a methadone service to drug users are given in 
Table IV. Four of the five most frequent reasons were common to Dublin and 
Glasgow. The most common reason for not providing methadone services to drug 
users was “business reasons—risk to staff, property, theft”. Of respondents who did 
not provide a methadone service, 69% of Dublin respondents (n=91) and 55% of 
Glasgow respondents (n=22) indicated this as a reason. Some of the reasons for not 
providing a service given in the open-text area of the questionnaire are transcribed 
below: 
This is a mainly middle-class area and, while we are aware that drug problems do 
exist locally, we believe local opposition to these services would be immense, as 
many addicts would come in to the area. (Dublin pharmacist) 
The nature of their addiction makes them untrustworthy, irrational, difficult to deal 
with, governed by strange standards of behavior which are not acceptable. (Dublin 
pharmacist) 
More control required to make scheme work. Proper prescribing control, patient 
registration, supervision, etc. required to reduce current substantial abuse of the 
scheme. (Dublin pharmacist) 
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Very quiet pharmacy in an affluent area therefore do not really have that type of 
customer. (Glasgow pharmacist) 
Not enough training/counselling given and don't see any great end result—are we not 
just creating methadone junkies—letting them become dependent on never 
decreasing quantities. (Glasgow pharmacist) 
The nearby pharmacy (same owner) provides methadone services. (Glasgow 
pharmacist) 
Quiet area is beside dispensary. (Glasgow pharmacist) 
Table IV. Most frequent reasons for not providing a methadone service for drug 
users. 
Dublin (n=91) Glasgow (n=22) 
Business reasons, risk to staff, property, theft (69%) Business reasons, risk to staff, property, theft (55%) 
Concern that other customers would object (63%) Concern that other customers would object (46%) 
Premises are not suitable for supervision of 
consumption (54%) No request for such a service (46%) 
No request for such a service (47%) Pharmacy is too busy to provide an efficient service (32%) 
It is company policy/owner's decision (41%) It is company policy/owner's decision (32%) 
Views of non-providers on what circumstances, if any, would lead them to 
provide a methadone service in the future  
Of the 91 Dublin pharmacies that did not provide a service, 82 provided comments 
on future service provision, of which 39 were positive and suggested that they may 
provide this service in the future. Of the 22 Glasgow pharmacists, 14 provided 
comments, of which seven were positive and indicated that they may provide this 
service in the future. Comments made on what might lead the pharmacist to provide 
a methadone service in the future were varied but could be broadly classified into 
four or five main categories, as listed in Tables Vi and Vii for Dublin and Glasgow 
respectively. It appears that some pharmacists would be willing to provide a 
methadone service to drug users if the demand for such a service increased. A 
number indicated a willingness to operate the service if it could be confined to the 
locality, dealing with local patients and doctors. The issue of operating within an 
established scheme was also highlighted, as was a need for increased security 
before they would get involved. However, a number of negative comments indicate 
that some pharmacists will not voluntarily offer this service irrespective of 
circumstances. 
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Table Vi. Sample of comments made by pharmacists in Dublin not providing a 
methadone service on what might lead them to provide such a service in the 
future (open text area results). 
Category Examples of comment 
Demand/need for service “Increased demand for such a service in the area.” 
Confine service to locality and cooperation within 
locality—GPs and pharmacists 
“Discussion with local doctors/prescribers—if they 
requested us to provide this service for patients living 
in this area.” 
Established scheme “A strictly controlled scheme where each patient has the support of a sponsor.” 
Increased security “I would be in agreement if, and only if, security aspects for staff and public were not jeopardized.” 
Negative comments “Nothing on earth.” 
“When practical measures are put in place to 
assist the victims of drug abusers.”  
“I don't think I can give an efficient and caring 
service which I think should be done in a clinic 
with pharmacist, doctor, counselling.” 
 
 
Table Vii. Sample of comments made by pharmacists in Glasgow not providing 
a methadone service on what might lead them to provide such a service in the 
future (open text area results).
Category Examples of comment 
Demand/need for service “Would do in future if demand/need arose.” 
“If asked would provide this service.”  
Established scheme “On a small scale with agreed appointment for supervision it might be acceptable.” 
Increased security “Funding to provide another more suitable quiet area.” 
Negative comments “Having provided such a service in the past to my great cost I would not provide such a service again.” 
“We don't foresee our doing this.”  
“Only legal compulsion to do this service.”  
“I can't think of anything that would convince me 
to do this.”  
“A lot of persuasion if such a need arose.”  
Views of current providers on why they provide a methadone service  
Four of the top five reasons indicated for providing a methadone maintenance 
service were common to Dublin and Glasgow, as shown in Table VI. The top reason 
indicated by both Dublin (76%) and Glasgow (92%) pharmacists for providing a 
methadone service to drug users was “perceived professional responsibility to 
provide such a service”. Some of the reasons for providing a service given in the 
open-text area are transcribed below: 
 
No money could pay for doing this.  A desire to remain alive while working in a 
pharmacy in an inner city area. (Dublin pharmacist) 
I don't think methadone therapy works, but it indicates a desire to stop heroin. I feel I 
cannot supply and charge for treatment for one sick person and then reject another, 
i.e. the junkie. (Dublin pharmacist) 
If a strong support unit—family is available—we can then deal with family and not 
with addict directly. (Dublin pharmacist) 
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We only supply to patients from our area. Local GP in our area does prescribe for 
people outside area. We refuse to dispense to these. (Dublin pharmacist) 
Methadone programmes may not be clinically effective in that there aren't many 
patients reducing and becoming drug free. But it does give patients a “chance” and is 
reducing injecting. Best method available. (Glasgow pharmacist) 
Table VI.  Most frequent reasons for providing a methadone service for drug 
users. 
Dublin (n=55) Glasgow (n=90) 
Perceived professional responsibility to provide 
such a service (76%) 
Perceived professional responsibility to provide 
such a service (92%) 
Requested by GPs/clinics to provide a service 
(73%) 
Support of the provision of services to drug 
misusers (80%) 
Support of the provision of services to drug 
misusers (67%) 
Requested by GPs/clinics to provide a service 
(67%) 
Requested by patients to provide a service (51%) Methadone programmes considered to be clinically effective (66%) 
It is company policy/owner's decision (38%) Requested by patients to provide a service (57%) 
Numbers of patients per pharmacy and types of services provided  
The number of patients per pharmacy, for which methadone services were provided, 
is shown in Table VII. From these data it can be seen that the majority of pharmacies 
in Glasgow (60%) dealt with 10 or more patients. This is in contrast to the equivalent 
figure for Dublin (31%). Overall 47% of pharmacies in Dublin dealt with three patients 
or fewer. 
Table VII. Number of patients per pharmacy receiving methadone services. 
No. of patients per pharmacy receiving methadone services Dublin Glasgow 
≤3 26 (47%) 16 (18%) 
4-9 12 (22%) 18 (20%) 
≥10 17 (31%) 54 (60%) 
Not declared 0 (0%) 2 (2%) 
Total 55 (100%) 90 (100%) 
Methadone-dispensing services were categorized as 7 days daily supervised, 6 days 
daily supervised with take home for Sunday, daily take home, weekly take home and 
other (which included 5 days supervised with take home for Saturday and Sunday 
and two to three times weekly take home). Details of numbers of pharmacies that 
provided these services and numbers of patients dispensed methadone in each of 
these categories is given in Tables VIIIi and VIIIii for Dublin and Glasgow 
respectively. (Note that numbers exceed 100% owing to the fact that a particular 
pharmacy may provide more than one category of methadone dispensing.) The vast 
majority of patients in Dublin (74%) received their methadone in the form of weekly 
take-home supply. By contrast, the vast majority of patients in Glasgow (72%) 
received daily supervised consumption with a take-home dose for Sunday. In Dublin, 
nine (16%) pharmacies provided supervised dispensing of methadone on 6 or more 
days per week to a total of 151 (21%) patients. This is in contrast to the situation in 
Glasgow, where 76 (84%) pharmacies provided this same supervised service to a 
total of 1,191 (76%) patients. 
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Table VIIIi. Number of pharmacies and patients for each category of methadone 
dispensing in Dublin. 
Category of methadone dispensing No. pharmacies No. patients Total no. patients 
 n=55 ≤3 4-9 10-29 ≥30   
Daily supervised 4 1 1 1 1  60 (8%) 
Supervised daily, Sunday take home 7 5 0 0 2  91 (12%) 
Daily take home 11 9 1 1 0  34 (5%) 
2-3 times weekly take home 2 2 0 0 0  3 (1%) 
Weekly take home 50 28 8 10 4  546 (74%) 
Total 74 43 10 12 7  734 (100%) 
 
Table VIIIii. Number of pharmacies and patients for each category of 
methadone dispensing in Glasgow. 
Category of methadone dispensing No. pharmacies No. patients Total no. patients 
 n=90 ≤3 4-9 10-29 ≥30  
Daily supervised 10 6 1 3 0 58 (4%) 
Supervised daily, Sunday take home 70 16 12 30 12 1133 (72%) 
Daily take home 49 34 14 1 0 139 (9%) 
Weekly take home 47 43 4 0 0 90 (6%) 
Othera 16 10 1 2 3 157 (10%) 
Total 192 109 32 36 15 1577 (100%)  
aFive days' supervised consumption with Saturday and Sunday take home or 2-3 times weekly take 
home. 
Privacy  
In Dublin, 12 (22%) pharmacies had a private area suitable for supervision of 
methadone consumption, while in Glasgow 42 (47%) pharmacies had such a facility. 
Of those that provided a private area, this same area was routinely used for general 
patient advice in 50% of pharmacies in Dublin and 62% of pharmacies in Glasgow. 
Information requests from patients  
Pharmacists in Glasgow had a higher number of requests for information from 
patients compared with Dublin (53% vs. 16%). In dealing with these requests, 
Glasgow pharmacists provided verbal information more often than Dublin 
pharmacists (100% vs. 60%) and were more likely to provide information leaflets to 
support this advice (27% vs. 8%). In addition, in response to requests for advice, 
32% of Dublin pharmacists referred the patient back to the prescriber or clinic 
compared with 27% of Glasgow pharmacists. 
Operational procedures  
Written procedures/guidelines  
In Glasgow, 71% of pharmacists had written procedures/guidelines for the provision 
of methadone services. This was significantly greater than the 40% of Dublin 
pharmacists who had written procedures/guidelines in place (χ2=13.7, df=1, 
p<0.001). 
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Formulations  
The three most common formulations in use were a 1 mg/ml mixture (45%), a 1 
mg/ml sugar-free mixture (36%) and a 2 mg/5 ml linctus (19%). The sugar-containing 
linctus formulation was dispensed by 69% of pharmacies in Dublin but by only 1% of 
pharmacies in Glasgow. In Glasgow, the 1 mg/ml sugar-containing mixture appeared 
to be prescribed more frequently than the sugar-free equivalent, with 93% of 
Glasgow pharmacies dispensing the 1 mg/ml sugar-containing mixture, whilst only 
50% dispensed the sugar-free formulation. In Dublin, the reverse was seen, with 16% 
dispensing the sugar containing and 55% dispensing the sugar-free formulation. 
Preparation and storage  
The majority of pharmacists in Glasgow (90%) prepared doses in advance compared 
to a minority in Dublin (20%). Of those who prepared doses in advance, 56% in 
Glasgow and 64% in Dublin stored these doses in the safe or Controlled Drug (CD) 
cupboard prior to dispensing. The majority of pharmacists used standard dispensing 
containers (amber glass or plastic bottles). In addition, 23% of pharmacists in 
Glasgow and 10% in Dublin provided a cup/container for immediate consumption. 
Record keeping  
The percentage of pharmacies that recorded methadone dispensing on their patient 
medication records was 89% and 85% for Glasgow and Dublin respectively. In 
Dublin, 66% of pharmacies made entries in the CD register at the time of dispensing, 
25% did so at the end of the day and 9% made CD entries on the day following 
supply. In Glasgow, the equivalent percentages were 44%, 50% and 6% 
respectively. Running stock balances in the CD register were maintained by 89% of 
Dublin pharmacists compared with 7% of Glasgow pharmacists. 
Indemnity insurance  
The vast majority of pharmacists in both Dublin (89%) and Glasgow (87%) did not 
know if their indemnity insurance covered them for supervising methadone 
consumption on the premises. Only 4% of Dublin pharmacists and 13% of Glasgow 
pharmacists were sure that their insurance covered this service. 
Patient contracts  
The percentage of pharmacies that had patient contracts was similar in Glasgow and 
Dublin (48%, 43/90, and 42%, 23/55, respectively). However, of those that had 
patient contracts, the percentage that had written contracts was lower in Glasgow 
than in Dublin (51%, 22/43, vs. 74%, 17/23, respectively). 
Withholding methadone doses  
A number of pharmacists indicated that they had withheld/refused a dose. Figures 
were 54% and 40% for Glasgow and Dublin respectively. Pharmacists were asked to 
state in what circumstances they would withhold a dose of methadone. Free-format 
text responses could be classified into seven main categories as detailed in Table IX. 
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Table IX. Number of respondents who would withhold a dose of methadone 
under particular circumstances. 
Category Dublin Glasgow 
Irregularity with respect to the prescription 16 7 
Patient presenting for methadone at “incorrect” time (too early or too late) 13 20 
Abusive/unacceptable behaviour 12 39 
Patient appeared to be intoxicated (alcohol or other substance) 10 61 
On advice of GP 4 11 
Shoplifting 2 10 
Other 9 3 
In Dublin, the most likely reason for withholding a dose was in circumstances of 
irregularity with respect to the prescription. Comments made in this regard included: 
“suspected forgery/alteration”; “prescription written wrongly”; “script does not meet 
legal requirements”; “any alteration of prescription by patient”; “believed to be 
acquiring it from multiple sources”. 
This problem was less frequently identified in the Glasgow responses where it rated 
sixth in the seven categories identified. In Glasgow, the most likely reason for 
withholding a dose was intoxication with alcohol or other substances. Comments 
made included: “patient very intoxicated”; “illicit use of methadone”; “patient under the 
influence of other substances”; “only in very severe circumstances—taking it would 
endanger health”; “intoxication (although this is difficult to know if they use 
cannabis)”; “if someone was totally spaced out”. 
Providers' views on future service developments  
Views with respect to improving available preparations were obtained—at the time of 
the study pharmacists from Dublin were twice as likely to want changes in strengths 
of available preparations, volume, packaging and form. Pharmacists were asked to 
identify the ideal formulation for the future. Greatest support was obtained for liquid 
formulations at 57% and 55% for Dublin and Glasgow respectively. Tablets were the 
second choice for both with dispersible formulations preferred. A few comments 
expressing a preference for an oral sustained release preparation and a 24-h patch 
were made. 
Pharmacists were questioned as to whether they believed that those supervising 
methadone consumption should hold a supply of naloxone injection for use in an 
emergency and whether such pharmacists should be trained to administer naloxone 
in such circumstances. The responses to the questions regarding attitudes to the 
supply and administration of naloxone are given in Tables Xi and Xii for Dublin and 
Glasgow respectively. 
Table Xi. Responses to naloxone questions from Dublin pharmacists providing 
methadone services. 
Service 
provided 
Total no. 
respondents 
Hold supply of 
naloxone 
Be trained to 
administer naloxone 
Both hold a supply 
and be trained 
Supervised 9 6 (67%) 7 (78%) 6 (67%) 
Non-
supervised 45 23 (51%) 23 (51%) 22 (49%) 
Unknown 1 1 (100%) 0 (0%) 0 (0%) 
Total 55 30 (55%) 30 (55%) 28 (51%) 
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Table Xii. Responses to naloxone questions from Glasgow pharmacists 
providing methadone services. 
Service 
provided 
Total no. 
respondents 
Hold supply of 
naloxone 
Be trained to 
administer naloxone 
Both hold a supply 
and be trained 
Supervised 76 26 (34%) 38 (50%) 26 (34%) 
Non-
supervised 8 3 (38%) 3 (38%) 2 (25%) 
Unknown 6 2 (33%) 3 (50%) 2 (33%) 
Total 90 31 (34%) 44 (49%) 30 (33%) 
A higher percentage of Dublin pharmacists felt that pharmacists supervising 
methadone consumption should hold a supply of naloxone compared with Glasgow 
pharmacists (55% vs. 34%). In addition, 55% of Dublin pharmacists felt that 
pharmacists should be trained to administer naloxone compared with 49% of 
Glasgow pharmacists. Overall, 51% of Dublin pharmacists and 33% of Glasgow 
pharmacists felt that pharmacists providing supervised consumption should both hold 
stock and be trained to use it in an emergency. 
DISCUSSION  
The response rate to the questionnaire was low at 50% and 55% for Dublin and 
Glasgow respectively. However, this level may be considered reasonable for a 
lengthy questionnaire containing 45 items, distributed by post with no reminder. 
Overall, 68% (76/112) of Glasgow respondents supervised methadone consumption. 
This figure is the same as that reported by Roberts et al. in 1998 for the total number 
of pharmacies in Glasgow providing a supervised methadone service (Gruer et al., 
1997). The structured methadone scheme in Glasgow is entirely funded by the NHS; 
therefore, we conclude that the findings are generalizable to Glasgow. By contrast, 
there was no equivalent state-funded scheme in Dublin; therefore, GPs were issuing 
private prescriptions at this time (Pharmaceutical Society of Ireland, 1996). Data on 
such private prescriptions are not collated centrally. Therefore, caution should be 
used in generalizing the Dublin findings. 
The differences in the level of participation in the provision of methadone dispensing 
services between Dublin and Glasgow (38% vs. 80%) were significant but not 
surprising in light of the formal scheme in Glasgow and the absence of an equivalent 
scheme in Dublin (Irish Ministerial Task Force, 1996; Roberts et al., 1998) i.e., the 
different circumstances in which the two groups were operating. Gender and 
employment status (pharmacy owner or employee) were significantly different 
between respondents from Dublin and Glasgow. However, neither gender nor 
employment status significantly influenced whether methadone services were 
provided or not. Having considered year of registration, it was noticeable that Dublin 
pharmacists registered for 20 years or more were less involved in methadone 
dispensing services than any other group. The age profile is similar for pharmacists 
in Dublin and Glasgow and yet the same observation with respect to older 
pharmacists was not evident in Glasgow. The existence in Glasgow of a well-run, 
established scheme might be influencing older pharmacists to take part in the 
service. 
The profile of pharmacy type (single, small multiple, multiple, large multiple) was 
significantly different between Dublin and Glasgow; however, pharmacy type did not 
significantly influence whether methadone services were provided or not, with the 
exception of single pharmacies in Glasgow, which were less likely to provide 
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methadone services. We are unable to explain this finding. By contrast, volume of 
prescriptions was shown to have an impact on service provision in Dublin with 
pharmacies dispensing fewer than 2,000 items per month being less likely to provide 
this service. This is difficult to explain but somewhat ironic in light of the fact that the 
group with the most time and the most to gain by extending their services was the 
one with least involvement with this patient group. 
It was notable that Glasgow pharmacies had a tendency to provide a service for 
much larger numbers of patients than those in Dublin. This is despite the difference 
in service provision, with 84% (76/90) of service providers in Glasgow offering 
supervision on 6 or more days per week compared with only 16% (9/55) offering the 
same service in Dublin. It was surprising that pharmacists in Glasgow deal with such 
large numbers of patients given the time-consuming nature of supervision. However, 
this is probably attributable to the existence of a funded and well-managed 
programme in Glasgow, compared with the haphazard nature of the community 
pharmacy service in Dublin in November 1997. 
Despite the difference in participation levels, there was close agreement between 
pharmacists in the two cities who did not provide methadone services to drug users 
as to why they did not do so. The most common reason in both cities was “business 
reasons—risk to staff, property, theft”, while the second most common reason was 
also related to business, in that pharmacists feared that “other customers would 
object”. This finding is in agreement with previous studies of community pharmacists 
in the UK, which have shown that, although the majority feels that the community 
pharmacist has a role to play with drug users, particularly in HIV prevention, they also 
have concerns over personal safety and the effect that drug users in their 
pharmacies may have on business (Harding, Smith, & Taylor, 1992; Glanz et al., 
1998; Sheridan & Barber, 1997; Sheridan, Strang, Taylor, & Barber, 1997). These 
attitudes may be due to personal experience or awareness of anecdotal reports of 
violent or threatening incidents that have occurred in community pharmacies. 
In 1996, Smith and Weidner conducted a survey of community pharmacists in the 
London area with a view to identifying the frequency of threatening and violent 
incidents experienced by community pharmacists (Smith & Weidner, 1996a, b). Fifty-
one per cent of respondents reported that they or their staff had at some time been 
threatened with violence and 31% had been assaulted. Pharmacists described the 
perpetrators of 15% of incidents as “drug addicts” (Smith & Weidner, 1996a). 
Services to intravenous drug users, in particular the dispensing of controlled drugs 
and participation in needle exchange schemes, were clearly affected by security 
concerns of pharmacists (Smith & Weidner, 1996b). The results of the present study 
also support the recommendation of Sheridan and Barber (1997a) that further 
attention needs to be paid to the fears among some pharmacists that drug users in 
the pharmacy will adversely affect business. 
The one reason put forward by Dublin pharmacists for not providing a methadone 
service, which was not reflected in Glasgow pharmacists' responses, was that “the 
premises (were) not suitable for supervision of consumption”. The level of supervised 
consumption of methadone in the community pharmacy was found to be much higher 
in Glasgow than in Dublin. In 1996, an area pharmacy specialist for drug misuse was 
appointed in Glasgow, with responsibilities including the coordination and facilitation 
of community pharmacists concerned with methadone dispensing and supervision 
(Gruer et al., 1997; Roberts et al., 1998). Under the programme in operation in 
Glasgow, pharmacists are encouraged to provide an area suitable for the supervision 
of methadone consumption by patients and many pharmacists have adapted their 
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premises in this manner. An objective of the new scheme established in Dublin, 
subsequent to the legislation that was introduced in 1998 (Irish Misuse of Drugs 
Regulations, 1998), is similarly to encourage pharmacists to become involved in the 
supervision of consumption of methadone and to provide facilities on their premises 
suitable for such an activity. 
Some of the comments explaining why pharmacists do not provide a methadone-
dispensing service to drug users or what might lead them to provide one in the future 
(Tables Vi and Vii) reflected a need, particularly in Dublin, to establish a more 
structured scheme with tighter controls on prescribing and dispensing practices. 
Such a scheme is now underway in Dublin subsequent to the introduction of new 
legislation, and it will be interesting to note the impact on pharmacists' attitudes to 
service provision. 
A belief that methadone programmes are clinically effective did not rank among 
Dublin pharmacists' top five reasons for providing methadone services (only 35% of 
providers compared with 66% in Glasgow). Pharmacists' expectations of methadone 
programmes were not examined in detail in this study, but comments in the open-text 
areas of the questionnaire suggest that some pharmacists measured the worth of 
such programmes in terms of their success in detoxification and placed little value on 
maintaining patients free of street drugs in the absence of methadone dosage 
reduction. Further education or dissemination of information to highlight the additional 
benefits of methadone programmes might therefore be worthwhile. However, 
pharmacists in Dublin who did not participate in methadone-dispensing services did 
not rate “methadone programmes are considered to be ineffective” among their top 
five reasons for not providing methadone services to drug users. The fact that 76% of 
Dublin methadone service providers and 92% of Glasgow service providers 
perceived a “professional responsibility to provide such a service” is an encouraging 
indicator of the professionalism of pharmacists in both regions. Some of the 
comments provided in the open-text area might suggest other motives for 
involvement in such service provision, for example: “No money could pay you for 
doing this. A desire to remain alive while working in a pharmacy in an inner city area.” 
This may imply that this participating Dublin pharmacist perceives that his satisfied 
service users provide a “protection service” to the pharmacy! Alternatively other 
pharmacists could hold this view as a reason for not getting involved. This study is 
unable to provide deeper insight into this aspect and further research is therefore 
required to obtain a better understanding of pharmacists' motives for providing such 
services. 
The result of this 1997/1998 study was that overall 68% (76/112) of Glasgow 
respondents supervised methadone consumption. This figure is the same as that 
reported by Roberts et al. in 1998 for the total number of pharmacies in Glasgow 
providing a supervised methadone consumption service. This high rate of supervision 
was in contrast to the situation in Dublin, where pharmacists were not paid for 
providing the service, and only 6% (9/146) of respondents did so. Despite the high 
levels of supervised consumption in Glasgow, only 47% of pharmacies had a private 
area available for supervision. However, this did not seem to impact adversely on the 
level of verbal advice given by pharmacists in Glasgow, which was 100%, compared 
with 60% in Dublin. 
Glasgow pharmacists had a high level of written procedures (70%), usually prepared 
doses in advance (90%) and maintained patient medication records for methadone 
(89%). These findings are perhaps not surprising given the high involvement of 
Glasgow pharmacists in an established programme. What is surprising, however, is 
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that only 23% provided a cup or container for consumption and only 48% had 
contracts with patients, of which as few as half were written contracts. Perhaps the 
most intriguing revelation is the fact that 87% did not know if they had professional 
indemnity insurance cover for supervised consumption, with 13% certain that they 
had cover. Dublin pharmacists had a much lower level of written procedures (40%) 
and rarely prepared doses in advance (20%), though they maintained high levels of 
patient medication records for methadone (85%) with 42% having contracts with 
patients, of which 78% were written. Like their Glasgow counterparts, a high 
proportion (89%) did not know if they had professional indemnity insurance cover for 
supervised consumption, with only 4% certain that they had cover and a worrying 7% 
reporting that they did not. 
Glasgow pharmacists tended to withhold doses more often than Dublin pharmacists. 
The range of circumstances in which they would withhold a dose was similar for the 
two groups; however, the ranking varied considerably. Dublin pharmacists appeared 
to be most concerned with prescription irregularities and “incorrect” time of collection, 
whilst Glasgow pharmacists were more concerned with levels of intoxication and 
abusive behaviour. This could perhaps be explained by the stark differences in 
service provision between both cities, with Dublin pharmacists more likely to 
dispense weekly take home for fewer than three patients and Glasgow pharmacists 
providing daily, supervised prescriptions for more than 10 patients. 
With respect to future service provision and possible formulation changes, 
pharmacists in Dublin appeared to be less satisfied with existing formulations. This 
probably reflected the use of the 2-mg/5-ml linctus, which was the most commonly 
used formulation in Dublin at the time of the study. This is no longer a problem, as 
the linctus can no longer be used for the treatment of opiate dependence under the 
new scheme in the Republic of Ireland. Subsequent to this study, a structured 
scheme was introduced in Dublin in late 1998 following the enactment of the Irish 
Misuse of Drugs Regulations (1998). These regulations made provision for the 
maintenance of a central treatment list of patients and the issuing of drug treatment 
cards, valid for a maximum period of 1 year. Restrictions on prescribing and 
dispensing practices and record-keeping requirements by the Irish Department of 
Health and Children and the pharmacy are also stipulated in the regulations. 
Naloxone is the antidote of choice for the treatment of methadone overdose. Strang 
and colleagues. (Strang, Darke, Hall, Farrell, & Ali, 1996; Strang et al., 1999) have 
argued that an inadequate response to overdoses is a major cause of fatalities 
among heroin users. They argued that home-based supplies of naloxone would save 
lives because they might enable family or friends to effect emergency resuscitation in 
the critical period between the sudden onset of heroin overdose and eventual 
naloxone administration by a health care professional. Pharmacists' attitudes to 
holding a supply of naloxone for use in an emergency varied considerably between 
the two cities, with 55% support in Dublin and 34% in Glasgow. Support for training 
to administer naloxone was similar in both Dublin and Glasgow, at 55% and 49% 
respectively. It was notable that Dublin pharmacists had a more positive attitude 
towards this new service development, despite having a lower level of supervision 
(16% vs. 84% for Glasgow). Surprisingly fewer Glasgow pharmacists supported the 
stocking of naloxone for administration in an emergency than were prepared to 
undertake the necessary training to deliver this service (34% vs. 49%). This seems 
irrational in that, if training were provided to those who responded positively, then 14 
trained pharmacists (16%) would have no drug to administer. This is an unexpected 
response, considering the risks involved and the legal implications of administering 
an injectable drug. 
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CONCLUSION  
Significant differences were found and described in the provision of methadone-
dispensing services between Dublin and Glasgow. Most notable were: pharmacists' 
participation levels, extent of supervised service provision and numbers of patients 
per pharmacy, all of which were higher in Glasgow, where there was a structured 
methadone scheme in place for a number of years prior to the study. 
Despite these differences in service provision, when grouped as providers and non-
providers of methadone services, views were very similar in both cities. This research 
lent support to the implementation of a structured methadone scheme in Dublin in 
October 1998 and informed changes to the established Glasgow scheme. The 
second paper (in preparation) in this series reports on the evolution of methadone 
services in both cities in the 5-year period to 2002. 
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